The Scientist

» drug development, evolution and immunology

Most Recent

image: Zooming In on an Antidepressant Target

Zooming In on an Antidepressant Target

By | April 6, 2016

Structural studies reveal how SSRI drugs bind to the human serotonin transporter.

0 Comments

image: One Way Placenta Deflects Zika Infection

One Way Placenta Deflects Zika Infection

By | April 5, 2016

Certain immune cells surrounding the organ appear to block viral entry.

0 Comments

image: Accomplished Biophysicist Dies

Accomplished Biophysicist Dies

By | April 5, 2016

Harold Morowitz, who dedicated his career to investigating the origins of life, has passed away at age 88.

0 Comments

image: Capsule Reviews

Capsule Reviews

By | April 1, 2016

Lab Girl, The Most Perfect Thing, Half-Earth, and Cosmosapiens

0 Comments

image: Guts and Glory

Guts and Glory

By | April 1, 2016

An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.

1 Comment

image: Tumor Traps

Tumor Traps

By | April 1, 2016

After surgery to remove a tumor, neutrophils recruited to the site spit out sticky webs of DNA that aid cancer recurrence.

0 Comments

image: Another Drug Price Hike

Another Drug Price Hike

By | March 28, 2016

Valeant Pharmaceuticals is criticized for jacking up the price of a drug used in assisted suicide.

0 Comments

image: Minimal Genome Created

Minimal Genome Created

By | March 24, 2016

Scientists build a living cellular organism with a genome smaller than any known in nature.

2 Comments

image: Brains Before Brawn

Brains Before Brawn

By | March 16, 2016

A newly described horse-size relative of Tyrannosaurus rex may help settle the question of how massive carnivorous dinosaurs took shape throughout the eons.

0 Comments

image: Cannabis-Based Drug for Epilepsy

Cannabis-Based Drug for Epilepsy

By | March 14, 2016

A marijuana-derived compound shows continued success in treating children with a rare form of the seizure disorder. 

0 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech